Pantson Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.70 Cr
as on 24-10-2024
- Revenue 0.47%
(FY 2023)
- Profit -29.75%
(FY 2023)
- Ebitda 0.52%
(FY 2023)
- Net Worth 41.71%
(FY 2023)
- Total Assets 38.02%
(FY 2023)
About Pantson Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.70 Cr.
Urmila Vemula and Monica Pant serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PTC235942
- Company No.
235942
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationThane, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pantson Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Urmila Vemula  | Director | 01-Jul-2021 | Current |
| Monica Pant | Director | 04-Mar-2019 | Current |
Financial Performance of Pantson Pharma.
Pantson Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.47% increase. The company also saw a substantial fall in profitability, with a 29.75% decrease in profit. The company's net worth Soared by an impressive increase of 41.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pantson Pharma?
In 2023, Pantson Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rinica Pharma Private LimitedActive 10 years 4 monthsUrmila Vemula and Monica Pant are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 23 Jun 2023 | ₹5.00 Cr | Open |
Axis Bank Limited Creation Date: 15 Apr 2022 | ₹3.70 Cr | Open |
How Many Employees Work at Pantson Pharma?
Pantson Pharma has a workforce of 25 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pantson Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pantson Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
